Peer Review reports
From: Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
| Original Submission | ||
|---|---|---|
| 8 Aug 2017 | Submitted | Original manuscript |
| 19 Aug 2017 | Author responded | Author comments - Malgorzata Banys-Paluchowski |
| Resubmission - Version 2 | ||
| 19 Aug 2017 | Submitted | Manuscript version 2 |
| 21 Oct 2017 | Reviewed | Reviewer Report - Julie E. Lang |
| 19 Nov 2017 | Author responded | Author comments - Malgorzata Banys-Paluchowski |
| Resubmission - Version 3 | ||
| 19 Nov 2017 | Submitted | Manuscript version 3 |
| 10 Dec 2017 | Reviewed | Reviewer Report - Julie E. Lang |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 21 Mar 2018 | Editorially accepted | |
| 8 May 2018 | Article published | 10.1186/s12885-018-4282-0 |
You can find further information about peer review here.